Yun Wang

3.6k total citations
119 papers, 2.1k citations indexed

About

Yun Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yun Wang has authored 119 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Yun Wang's work include Cancer Immunotherapy and Biomarkers (36 papers), Immunotherapy and Immune Responses (11 papers) and Inflammatory Biomarkers in Disease Prognosis (11 papers). Yun Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (36 papers), Immunotherapy and Immune Responses (11 papers) and Inflammatory Biomarkers in Disease Prognosis (11 papers). Yun Wang collaborates with scholars based in China, United States and United Kingdom. Yun Wang's co-authors include Rui‐Hua Xu, Hao‐Xiang Wu, Min Wang, Huai‐Qiang Ju, De‐Shen Wang, Yuhong Li, Harlan M. Krumholz, Zhao-Lei Zeng, Dong-sheng Zhang and Run‐Cong Nie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yun Wang

107 papers receiving 2.0k citations

Peers

Yun Wang

ONCOL

PRM

IMMUN

Ishmael Jaiyesimi United States

Rodney P. Rocconi United States

Agostino Steffan Italy

Ramez N. Eskander United States

Charles A. Leath United States

Rajen Mody United States

Giannis Mountzios Greece

Xiuhua Zhao United States

Irene Schmid Germany

Lisa Derosa France

Ishmael Jaiyesimi United States

Yun Wang

1.3k ×1.5

ONCOL

632 ×1.0

784 ×1.8

PRM

267 ×0.6

IMMUN

537 ×1.4

Citations per year, relative to Yun Wang Yun Wang (= 1×) peers Ishmael Jaiyesimi

Countries citing papers authored by Yun Wang

Since Specialization

Citations

This map shows the geographic impact of Yun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Wang more than expected).

Fields of papers citing papers by Yun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Wang. The network helps show where Yun Wang may publish in the future.

Co-authorship network of co-authors of Yun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Wang. A scholar is included among the top collaborators of Yun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Wang. Yun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yi, et al.. (2025). Acupoint Catgut Embedding Alleviates High-Fat-Diet Induced Obesity Through Activating Wnt/β-Catenin Pathway. 18(1).

Wang, Yun, Shuzhao Chen, Shutong Liu, et al.. (2025). The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma. Leukemia. 39(10). 2504–2515.

Thomas, Sajeve, Brian S. Henick, Rom S. Leidner, et al.. (2024). Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2542–2542.

Wu, Qi‐Nian, Ze-Kun Liu, Xiaojing Luo, et al.. (2024). HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer. Cancer Letters. 584. 216643–216643. 7 indexed citations

Wei, Wei, Yun Wang, Ting Wang, et al.. (2024). Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data. Annals of Surgical Oncology. 31(12). 7738–7749. 7 indexed citations

Wang, Yun, Rujia Chen, Ting Wang, et al.. (2024). Immunological profiling for short-term predictive analysis in PD-1/PD-L1 therapy for lung cancer. BMC Cancer. 24(1). 851–851. 2 indexed citations

Chen, Shuzhao, et al.. (2023). A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers. Frontiers in Pharmacology. 14. 1190660–1190660. 4 indexed citations

Li, Yuanfang, Shuqiang Yuan, Ying-Bo Chen, et al.. (2023). Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials. JNCI Journal of the National Cancer Institute. 115(9). 1085–1091. 7 indexed citations

Zhou, Jie, Run‐Cong Nie, Yixin Yin, et al.. (2022). Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy. Frontiers in Cell and Developmental Biology. 10. 906759–906759. 7 indexed citations

10.

Wang, Yun, Min Wang, Hao‐Xiang Wu, & Rui‐Hua Xu. (2021). Advancing to the era of cancer immunotherapy. Cancer Communications. 41(9). 803–829. 137 indexed citations

11.

Nie, Run‐Cong, Yun Wang, Jie Zhou, et al.. (2021). Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis. Frontiers in Oncology. 11. 538174–538174. 19 indexed citations

12.

Hu, Tao, et al.. (2020). Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC). Bioscience Reports. 40(6). 31 indexed citations

13.

Yuan, Bo, Yun Wang, Mingyang Li, et al.. (2020). Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis. International Journal of Colorectal Disease. 36(1). 117–130. 23 indexed citations

14.

Li, Shuman, Jie Zhou, Yun Wang, et al.. (2020). Recent Findings in the Posttranslational Modifications of PD-L1. Journal of Oncology. 2020. 1–7. 17 indexed citations

15.

Nie, Run‐Cong, Xiaowei Xia, Ting Wu, et al.. (2020). The Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta‐Analysis. BioMed Research International. 2020(1). 5059079–5059079. 7 indexed citations

16.

Wang, Yun, et al.. (2019). The Role of the HOXA Gene Family in Acute Myeloid Leukemia. Genes. 10(8). 621–621. 50 indexed citations

17.

Lu, Yun-Xin, Huai‐Qiang Ju, Zexian Liu, et al.. (2018). ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis. Cancer Research. 78(8). 1972–1985. 95 indexed citations

18.

Wang, Jiye, Mi Li, Yun Wang, & Xiaoping Liu. (2016). Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma. OncoTargets and Therapy. 9. 1221–1221. 15 indexed citations

19.

Wang, Yun, et al.. (2007). “America's Best Hospitals” in the Treatment of Acute Myocardial Infarction. Archives of Internal Medicine. 167(13). 1345–1345. 31 indexed citations

20.

Wang, Yun. (2006). Impact of Ginkogo Biloba Leaves on the Diethylnitrosamine-induced Liver Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact